| Ambrisentan - Wikipedia, the free encyclopedia Ambrisentan (U.S. trade name Letairis ; E.U. trade name Volibris INDIA trade name PULMONEXT -MSN LABORATORIES) is a drug indicated for use in the treatment of ... Read More |
| Letairis Web Site Letairis ® (ambrisentan) is a prescription medicine to treat pulmonary arterial hypertension (PAH), which is high blood pressure in the arteries of your lungs. Read More |
| Ambrisentan Treatment for Pulmonary Arterial Hypertension Ambrisentan Treatment for Pulmonary Arterial Hypertension. Ambrisentan is a vasodilator drug that has been developed by Myogen for the treatment of pulmonary arterial ... Read More |
| Ambrisentan Facts and Comparisons at Drugs.com All about Ambrisentan. View complete and up to date Ambrisentan information - part of the Drugs.com trusted medication database. Read More |
| Letairis (Ambrisentan Tablets) Drug Information: Description, User ... Learn about the prescription medication Letairis (Ambrisentan Tablets), drug uses, dosage, side effects, drug interactions, warnings, reviews and patient labeling. Read More |
| Ambrisentan Monograph | Drugs.com Ambrisentan reference guide from the American Society of Health-System Pharmacists. Ambrisentan guidance for safe and effective use. Read More |
| ambrisentan - MSN Health - Medications Ambrisentan prevents thickening of the blood vessels especially those in the lungs and heart. Ambrisentan also lowers blood pressure in your lungs h Read More |
| Pulmonary Hypertension Treatment Ambrisentan (Letairis ... Read about ambrisentan (Letairis), a treatment for pulmonary hypertension (PH). Read More |
| Newly Approved Drug Therapies (956) Letairis (ambrisentan), Gilead ... Letairis (ambrisentan) newly approved drug information on CenterWatch. ... Home » Drug Information » FDA-Approved Drugs » 2007 Medical Areas: Cardiology/Vascular ... Read More |
| Ambrisentan for the Treatment of Pulmonary Arterial Hypertension Ambrisentan for the Treatment of Pulmonary Arterial Hypertension Results of the Ambrisentan in Pulmonary Arterial Hypertension, Randomized, Double-Blind, Placebo ... Read More |
